|Articles|February 1, 2016
- Pharmaceutical Executive-02-01-2016
- Volume 36
- Issue 2
Pharmaceutical Executive, February 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Life and Lipitor: Pfizer's Traci Medford-Rosowabout 10 years ago
The Staying Power of Emerging Marketsabout 10 years ago
Canada's Rx&D: Fresh Start for a New Eraabout 10 years ago
Morgan Moments: A Closer Reading of the JP Morgan Investor Conferenceabout 10 years ago
Pharma dot-gov: A New Business Modelabout 10 years ago
The Creative Impulse: Defending Pharma and Health DTCabout 10 years ago
Securing Cipla’s Futureabout 10 years ago
Country Report: South AfricaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
3
How Do Recent Actions from FDA Provide Insight to the Agency's Enforcement Posture?
4
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
5